C losure of transcatheter patent ductus arteriosus was first performed in 1967 by Porstmann et al. [1] using Ivalon plug. Later on, transcatheter closure of patent ductus arteriosus using double disc umbrella device developed by Rashkind [2] in 1979 has been widely used in the world. [3] The closure of patent ductus arteriosus using coils was first reported in 1992 by Cambier et al. [4] and coils have been used more frequently in transcatheter closure of especially small, and moderately dilated patent ductus arteriosus. [5] In 1998, after the use of "Amplatzer Duct Occluder by Masura et al. for transcatheter closure of the medium-sized and large PDAs, the transcatheter approach has become the primary treatment method for closure of almost all PDAs. [6] With the introduction of occluders of various shapes and sizes, the transcatheter method has become the first choice for the closure of patent ductus arteriosus.
Although many articles have been published on transcatheter coil occlusion in patients with patent ductus arteriosus, these articles have shown shortterm results. [7] [8] [9] [10] [11] Since 1996, coils have been used in the closure of transcatheter patent ductus arteriosus in our center and these patients have been monitored by echocardiography. In this study, follow-up of the patients whose PDAs were closed with coil is presented.
METHODS
A total of 243 patients who underwent transcatheter closure of patent ductus arteriosus with a coil between May 1996 and May 2018 were included in the study. In the selection of the patients, the criteria in the guidelines published in 1998 and 2011. were applied. [12, 13] According to these criteria, patients with growth retardation, left atrium and left ventricular dilatation and presence of cardiac murmurs auscultated on physical examination were included in the closure procedures. Patients whose murmusr were not clearly heard but had significant arterial blood flow as detected on color Doppler echocardiographic examination and continuous flow sample was received with CW Doppler were also selected for closure procedure because any definite relevant contraindication does not exist in the guidelines.
In all patients, oscillation-controlled patent ductus arteriosus occlusion coils manufactured by Cook (Indiana, USA) were used. Approval was obtained from the local ethics committee before the study. The pa-tients were divided into two groups before and after the introduction of ductal occluders into clinical practice. Until the end of 2005, all cases with patent ductus arteriosus were closed with coils. Since ductal occluders were started to be used in our center in 2006, primarily occluders were preferred for transcatheter closure, while coils were mostly used for the closure of small, elongated and some complex PDAs.
All operations were performed by or under the control of a single surgeon (LS). In all patients, patent ductus arteriosus closure was performed under general anesthesia and sedation. After application of local anesthesia, venous, and in some patients both arterial, and venous sheaths were inserted using a percutaneous technique. Then 50-100 IU/kg heparin was administered. Priorly, contrast material was injected with the patient was laid at 90 ° left lateral decubitus position. If optimal images could not be obtained then injections were made with the patient at 30-40 ° right oblique, and + 10-30 ° cranial positions to determine the anatomy and diameter of the patent ductus arteriosus.
Patent ductus arteriosus was classified according to the criteria defined by Krichenko et al. [14] The diameter of the preferred coil was determined to be 1.5-2 times the narrowest diameter of patent ductus arteriosus. Closure was performed by transvenous and / or transarterial approach. Before the device was released, the location of the device and the presence of residual shunt were checked with the aid of the injection of contrast agent and the device was brought to the appropriate position in case of need. Antibiotic prophylaxis was applied to the patients after the procedure. After the procedure, the patients were hospitalized and followed up clinically.
All cases were evaluated by echocardiography at postprocedural 24.-48. hours, 1., 3., 6., and 12. months. Then, the patient was reevaluated clinically and echocardiographically at annual intervals. SPSS 15 system was used for statistical analysis. Data were expressed as medians or means. Reocclusion rates during long-term follow-up were determined by Kaplan Meier method.
RESULTS

Patients
A total of 243 patients who underwent transcatheter closure of patent ductus arteriosus with coil were in-cluded in the study. The median age of the patients was 4.33 years (9 months -39 years), median weight were 15 kg (5-55 kg) and median PDA diameter was 2 mm (1-4.5 mm). The study population consisted of 98 (40%) male and 145 (60%) female patients (Table  1) .
Angiographic features of ducts were classified as follows: Type A (conical) (n=126; 52%), type B (window) (n=15; 6%), type C (tubular) (n=6; 2.5%), type D (complex) (n=9; 3.7%) type E (elongated) (n=74; 30.5%) and other types (n=13; 5.3%) (postoperative residual patent ductus arteriosus in 9, and residual shunt after Rashkind Umbrella device application in 4 patients).
Additional cardiac pathologies were as follows; ventricular septal defect (n=16), aortic insufficiency (n=12), atrial septal defect (n=9) patients (one of them was closed via transcatheter route in the same session), bicuspid aortic valve (n=6), mitral valve prolapse (n=4), pulmonary stenosis (n=4) (2 patients underwent pulmonary balloon valvuloplasty in the same session), subvalvular aortic stenosis (n=2), supravalvular aortic One patient (0.4%) developed hemolysis after the procedure. This patient had a ductal diameter of 4.2 mm and a conical ductus. The dimensions of the coils used in the occlusion of the PDAs were 6.5x5 and 5x5 mm, respectively. One day later, hemolysis was treated with the insertion of an additional coil with the dimensions of 3x4 mm. Femoral artery occlusion was observed in five newborns. Three patients underwent embolectomy and two patients treated with heparinization. None of the patients had infective complications.
Follow-up
A total of 238 patients who underwent transcatheter closure with Cook coils were followed up by echocardiography for a median period of 26 months (1 day -19 years). Fifty (21%) patients were lost to followup after the control on the day of the procedure and 79 (33.2%) of them were followed up for more than 5 years. In 196 (82.3%) patients, complete occlusion was observed on the echocardiographic examination performed the day after the procedure. Four of the 42 patients who had residual shunts were seen after the procedure and could not be followed up afterwards. In 22 patients with residual shunts spontaneous occlusio occurred within the first year after the procedure and in the other 7 patients spontaneous closure occurred more than one year later.
Residual shunt closure occurred at the latest 3 years and 9 months after the procedure. In 13 patients stenosis (n=1), dextrocardia (n=1) and complete AV block (n=1) (pacemaker was implanted in the same session). Additional noncardiac pathologies included mental motor retardation (n=5), congenital rubella syndrome (n=4), Down syndrome (n=2), Williams syndrome (n=1), and meningocele (n=1).
Surgical procedures
The patent ductus arteriosus closure was completed in 183 patients (75.3%) using arterial route in 57, venous + arterial route in 57 (23.5%), and venous route in only 3 (1.2%) patients. In 238 of 243 patients, PDA was successfully closed with a coil. Of the 238 patients whose PDAs were successfully closed, 1 (n=222; 91.9%), 2 (n=15; 6.4%) and 3 (0.4%) coils were used in respective number of patients (Table 1) .
Complications
In 238 patients, patent ductus arteriosus was successfully closed with coils (Fig. 1) . The procedure was unsuccessful in five (2.2%) cases.
Coils were embolized in two cases (0.8%). Embolized coils were removed through transcatheter route.in both patients. Closure with an occluder was performed in one patient and the other patient underwent surgery. Coil occlusion was discontinued in three (1.2%) cases because the patent ductus arteriosus was not deemed to be suitable for coil closure after failed attempts. The ductal diameters of these three patients were 3.5, 4 and 4.5 mm, respectively. According to Kaplan Meier analysis, closure rates in coil closure procedures after long-term follow-up were 98.5%, and 95.6% after and before the year 2005, respectively (p=0.328) ( Fig. 3) . Any complication such as ductal recanalization or pulmonary artery and aortic stenosis was not observed during the longterm follow-up.
DISCUSSION
Closure of patent ductus arteriosus using coils has been applied since 1992. [4] For the first time in our country, in 1996, Aydoğan et al. [15] performed coil occlusion of patent ductus arteriosus. Since then, although many different devices have been used for transcatheter closure of patent ductus arteriosus, oscillation-controlled Cook coils and uncontrolled Gianturco coils have been widely used all over the world. Many studies have shown that closure of patent ductus arteriosus with Cook coil is a safe and effective method. However, in most of these studies short-term follow-up results have been reported.
Only a few articles have been published on the long-term results of coil closure of patent ductus arteriosus. [16] [17] [18] [19] In this study, we aimed to present the follow-up results of many patients.
In our study, the success rate of patent ductus arteriosus coil closure via transcatheter route was 94.6%. Various success rates for transcatheter coil closures have been reported (German joint study, 89%; Galal et al. 90.5%, [18] and Adams et al., 91% [21] ), but the success rate was reported as 100% in a study involving a smaller number of patients. [17, 20] Considering the number of patients in our study, the success rate was very high (97.9%). In our study, the coil was not released in three patients (1.2%) and the procedure was abandoned ( Fig. 1) . In all three patients whose PDA closure procedures were discontinued were intervened before the occluders were not introduced into clinical practice. In two of these patients, ductal diameters were considered to be extremely enlarged for coil closure. Although more than two or even seven coils have been used for transcatheter closure of large ducts in studies cited in the literature, believing that the use of more than two coils through transcatheter approach was not appropriate for the occlusion of patent ductus arteriosus with large ducts, closure procedure was prematurely terminated. [22] In one patient, long-lasting procedures and technical problems were the reasons for giving up. The ducts of these patients in whom the procedure failed due to the absence of occluders be- We preferred to wait or insert an extra coil instead of surgery. Within 24 hours, hemolysis completely disappeared with an additional coil inserted in the residual shunt. Other complications that may develop including ductal recanalization, portrusion of the device into left pulmonary artery and descending aorta were not seen in any of our cases. Similar to the study of Takata et al., [19] none of our patients required surgical intervention and intensive care.
Residual shunts are seen after both transcatheter and surgical closure of ductus arteriosus. [29] Previously, surgical ligation of ducts was thought to be a complete treatment, but with introduction of color Doppler echocardiography into clinical practice, clinically asymptomatic residual shunts have been demonstrated. [30] Zucker et al. [31] reported the residual shunt rate of 18% in postoperative color Doppler examinations, and 4.6% of their patients with residual shunts had a clinically apparent continuous murmur in the clinic. In our study of 325 cases, we found this rate to be 3.1%. [32] Since transcatheter closure of patent ductus arteriosus was introduced after routine use of color Doppler echocardiography, these patients were also monitored by color Doppler echocardiography in addition to clinical evaluations. Control angiographies performed after the occlusion procedure were not found to be sufficient, as in our study, all patients were followed up with color Doppler echocardiography the next day and thereafter. Magee et al. [23] reported the residual shunt rate as 5% in the first year after the procedure.
In the study of Takata et al., [19] the residual shunt rate was 3.6% in the first year and the occlusion rate in the long-term follow-up was 97.8%. In our study, the residual shunt rate was 17.7% and 6.5% at the end of the first year according to the echocardiographic examination findings performed on the day after the occlusion procedure. Complete occlusion rate was determined as 94.6% after long-term follow-up. Since the year 2006, the use of occluders in transcatheter closure of patent ductus arteriosus has changed our approach to ductal closure. For this reason, patients were evaluated in terms of residual shunts and divided into two groups during long and short term follow-ups.
Coils were applied to smaller and morphologically elongated ducts in 2006 and thereaafter. In both shortand long-term analyzes, no significant difference was found between residual shunt detection and complete fore the year 2005, were surgically closed. After introduction of occluders into clinical practice occluders were preferred for the closure of large ducts and any problem encountered during pre-occluder era was not experienced and occlusion of PDAs was not discontinued in any patient.
The arterial route is generally preferred for transcatheter closure of the duct. [23] In our study, only the arterial route was used in three fourths of the patients. For safer placement of the coil, more than one vascular access is used, and the position of the coil can be controlled by arterial contrast agent injections when the coil is inserted through the venous route. This method was especially preferred in our initial period and in wider ducts. In three of our patients, we used only the venous route recommended by Willcoxson et al. [24] We still use this method to occlude ducts with occluders, in order to avoid especially arterial complications.
Coil embolization is one of the most important complications of patent ductus arteriosus closure. Coil embolization was seen in two patients, one in each period. In our study ductal diameters of these patients were larger (3 and 3.5 mm) than the values reported in the literature. (The embolization rates reported in the literature ranged from 0 to 6.5%. [18, 25] The embolization rate in our study was at an acceptable level (0.8%). Embolized coils were removed through transcatheter route in both patients. While the first patient who applied during pre-occluded peirod underwent surgery, in the second patient it was possible to close the patent ductus arteriosus in the same session and by the transketeter route since occluders are being used since the year 2006.
Hemolysis is another important complication of transcatheter duct closure. Rates of hemolysis are lower than other complications. In patients with residual shunt, hemolysis may occur due to mechanical etiologies. The rate of hemolysis was reported to be 1% in the German joint study and 0.9% in the European joint study of 1258 patients [17, 23] When hemolysis occurred for the treatment residual shunt may be either closed with an additional coil or surgical closure may be applied. [26, 27] In cases where hemolysis is not so severe, resolution of hemolysis has been reported after watchful waiting. [28] In our study, only one patient (0.4%) developed hemolysis after the procedure.
closure rates. In their study Takata et al., [19] divided patients into groups according to ductal diameters (small, medium and large) and time of applications of closure (early and late). In this study, the closure rate of small ducts was found to be significantly higher. Although the complete occlusion rate was higher in the long term as in our study, the difference between early and late period was not significant. Although any significant difference was not found between the residual shunt rates in our study, since currently complete closure rates achieved with occluders reach up to 100%, we think that the priority should be given to occluders in transcatheter occlusion of patent ductus arteriosus, and coils have a restricted area of usage.
In the long-term, patients with patent ductus arteriosus closure using devices are monitored to determine the potential presence of residual shunt, stenosis of the pulmonary artery and aorta.
In many centers, including our center, follow-up of these patients is performed regularly by echocardiography. Narayan et al. [33] followed up 430 patients whose patent ductus arteriosus was closed with different occluders for a median follow-up of 25.8 months, and concluded that if there is no residual shunt or pulmonary artery and aortic stenosis, regular follow-up by echocardiography is not indicated and the patients can be safely ruled out from follow-up. In our study, any pathological findings were not found at the end of long-term follow-up in patients without residual shunt or pulmonary artery and aortic stenosis during the short-term follow-up. However, since it would be a very radical suggestion to exclude patients from follow-up, we think it would be more rational to suggest that follow-up should be performed at wider intervals.
In conclusion, transcatheter closure rate of small, small-medium diameter patent ductus arteriosus using oscillation-controlled coils was 95% after follow-up. Residual shunts seen after the procedure tend to close. The rate of closure is higher in the years after the procedure and this rate does not change in a very long follow-up time.
